Author:
Bu S. Y.,Lucas E. A.,Franklin M.,Marlow D.,Brackett D. J.,Boldrin E. A.,Devareddy L.,Arjmandi B. H.,Smith B. J.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism
Reference51 articles.
1. Kurland ES, Cosman F, McMahon DJ et al (2000) Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers. J Clin Endocrinol Metab 85(9):3069–3076
2. Behre HM, Kliesch S, Leifke E et al (1997) Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. J Clin Endocrinol Metab 82(8):2386–2390
3. Orwoll E, Ettinger M, Weiss S et al (2000) Alendronate for the treatment of osteoporosis in men. N Engl J Med 343(9):604–610
4. Shimon I, Eshed V, Doolman R et al (2005) Alendronate for osteoporosis in men with androgen-repleted hypogonadism. Osteoporos Int 16(12):1591–1596
5. Venken K, Boonen S, Van Herck E et al (2005) Bone and muscle protective potential of the prostate-sparing synthetic androgen 7 alpha-methyl-19-nortestosterone: evidence from the aged orchidectomized male rat model. Bone 36(4):663–670
Cited by
66 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献